Filing Flows › Biolife Solutions (BLFS) › Q2 2026 › vs Q1 2026
Biolife Solutions (BLFS) Q2 2026 vs Q1 2026 (quarter over quarter)
Biolife Solutions's revenue rose $966K (+4%) from $27.5M in Q1 2026 to $28.5M in Q2 2026. Gross margin 64.2% against 63.6% (+0.6 pts).
Biolife Solutions, Q2 2026: revenue $28.5M (+22% year over year), operating margin 6.0%, net earnings $45.1M, operating cash flow $6.3M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Gross margin | 64.2% | 63.6% | +0.6 pts |
| Operating margin | 6.0% | 0.1% | +5.9 pts |
| Net margin | 158.4% | 4.3% | +154.1 pts |
| Free cash flow margin | 18.6% | -2.4% | +21.0 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $28.5M | $27.5M | $966K | +4% |
| Gross profit | $18.3M | $17.5M | $791K | +5% |
| Cost of revenue | $10.2M | $10.0M | $175K | +2% |
| Other income, net | $1.1M | $1.2M | −$164K | -13% |
| Operating profit | $1.7M | $27K | $1.7M | 63× |
| Operating expenses | $16.6M | $17.5M | −$878K | -5% |
| Pre-tax earnings | $2.8M | $1.2M | $1.5M | +121% |
| Research & development | $3.0M | $2.6M | $308K | +12% |
| Sales & marketing | $2.8M | $2.5M | $256K | +10% |
| General & admin | $10.7M | $12.2M | −$1.5M | -12% |
| Other operating costs | $157K | $85K | $72K | +85% |
| Income tax benefit | $42.4M | −$62K | $42.4M | — |
| Net earnings | $45.1M | $1.2M | $43.9M | 38× |
| Depreciation & amortization | $411K | $374K | $37K | +10% |
| Share-based compensation | $3.9M | $4.8M | −$952K | -20% |
| Working capital & other | $43.0M | $6.9M | $36.2M | +527% |
| Operating cash flow | $6.3M | −$491K | $6.8M | — |
| Free cash flow (OCF − capex) | $5.3M | −$658K | $6.0M | — |
| Capital expenditures | $1.0M | $167K | $876K | +525% |
Questions
How much did Biolife Solutions's revenue grow quarter over quarter in Q2 2026?
Biolife Solutions's revenue rose $966K (+4%) from $27.5M in Q1 2026 to $28.5M in Q2 2026. Gross margin 64.2% against 63.6% (+0.6 pts).